LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Coronavirus Linked to Neurological Disease in Humans

By LabMedica International staff writers
Posted on 11 Oct 2016
Image: A depiction of a surface view of coronavirus, which has now been linked to neurological disease (Image courtesy of the Institut National de la Recherche Scientifique).
Image: A depiction of a surface view of coronavirus, which has now been linked to neurological disease (Image courtesy of the Institut National de la Recherche Scientifique).
A case-study of fatal encephalitis has, for the first time, led researchers to discover a direct association with strain OC 43 of the human coronavirus (HCoV), providing confirmatory evidence for the hypothesis that this respiratory virus can cause certain neurological diseases of unknown origin such as multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and encephalitis.

A co-leader of the study was Prof. Pierre Talbot, of Institut Armand-Frappier Centre at Institut National de la Recherche Scientifique (INRS; Québec, Canada), who had first demonstrated the virus’s ability to invade the human central nervous system and suggested neuropathological effects. Other researchers conducting the study were also from University College London (UK) and from Great Ormond Street Hospital for Children NHS Foundation Trust (UK).

They studied the case of a very young patient, an 11-month-old boy, who died from encephalitis. He had presented severe immunodeficiency and received a stem cell transplant. Although most cases of encephalitis are caused by viruses or bacteria, pinpointing the cause can be particularly difficult in immunodeficient patients. In this case it was not possible to identify the pathogen using conventional techniques. The researchers used various other methods that allowed them to irrefutably identify the presence of human coronavirus strain OC-43 in the young patient’s brain tissue.

“Among the methods used, deep sequencing of biopsy materials provides an important tool for the diagnosis of unexplained encephalitis, particularly in immunodeficient patients who have undergone stem cell transplantation,” said Prof. Talbot. This breakthrough is significant because it will make it possible to use specific treatments better tailored to patient conditions.

The study, by Morfopoulou S et al, was published August 2016 in the New England Journal of Medicine.

Related Links:
Institut National de la Recherche Scientifique

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Gel Cards
DG Gel Cards

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more